scholarly journals Treatment of facial lipoatrophy, morphological asymmetry, or debilitating scars with the hyaluronic acid dermal filler Princess® FILLER

2018 ◽  
Vol Volume 11 ◽  
pp. 621-628 ◽  
Author(s):  
Daisy Kopera ◽  
Zrinka Ivezic-Schoenfeld ◽  
Ira G. Federspiel ◽  
Doris Grablowitz ◽  
Benjamin Gehl ◽  
...  
Keyword(s):  
Hyaluronic Acid ◽  
Dermal Filler ◽  
Morphological Asymmetry ◽  
Facial Lipoatrophy

Long‐term effectiveness of a hyaluronic acid soft tissue filler in patients with facial lipoatrophy, morphological asymmetry, or debilitating scars

2020 ◽  
Vol 19 (10) ◽  
pp. 2536-2541
Author(s):  
Doris Grablowitz ◽  
Zrinka Ivezic‐Schoenfeld ◽  
Ira G. Federspiel ◽  
Benjamin Gehl ◽  
Daisy Kopera ◽  
...  
Keyword(s):  
Hyaluronic Acid ◽  
Soft Tissue ◽  
Morphological Asymmetry ◽  
Facial Lipoatrophy ◽  
Soft Tissue Filler

scholarly journals Toward Physicochemical and Rheological Characterization of Different Injectable Hyaluronic Acid Dermal Fillers Cross-Linked with Polyethylene Glycol Diglycidyl Ether

Polymers ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 948
Author(s):  
Nicola Zerbinati ◽  
Sabrina Sommatis ◽  
Cristina Maccario ◽  
Maria Chiara Capillo ◽  
Giulia Grimaldi ◽  
...  
Keyword(s):  
Hyaluronic Acid ◽  
Polyethylene Glycol ◽  
Biological Activities ◽  
Diglycidyl Ether ◽  
Dermal Filler ◽  
Cross Linking ◽  
Matrix Structure ◽  
Dermal Fillers ◽  
Rheological Characterization

(1) Background: Injectable hyaluronic acid (HA) dermal fillers are used to restore volume, hydration and skin tone in aesthetic medicine. HA fillers differ from each other due to their cross-linking technologies, with the aim to increase mechanical and biological activities. One of the most recent and promising cross-linkers is polyethylene glycol diglycidyl ether (PEGDE), used by the company Matex Lab S.p.A., (Brindisi, Italy) to create the HA dermal filler PEGDE family. Over the last few years, several studies have been performed to investigate the biocompatibility and biodegradability of these formulations, but little information is available regarding their matrix structure, rheological and physicochemical properties related to their cross-linking technologies, the HA content or the degree of cross-linking. (2) Methods: Seven different injectable HA hydrogels were subjected to optical microscopic examination, cohesivity evaluation and rheological characterization in order to investigate their behavior. (3) Results: The analyzed cross-linked dermal fillers showed a fibrous “spiderweb-like” matrix structure, with each medical device presenting different and peculiar rheological features. Except for HA non cross-linked hydrogel 18 mg/mL, all showed an elastic and cohesive profile. (4) Conclusions: The comparative analysis with other literature works makes a preliminary characterization of these injectable medical devices possible.

Hand Rejuvenation With A Hyaluronic Acid-Based Dermal Filler: A 12-Month Clinical Follow-Up Case Series

2021 ◽  
Vol 20 (4) ◽  
pp. 451-459
Author(s):  
Patrick Micheels ◽  
Stéphanie Besse ◽  
Marc Sibon ◽  
Badwi Elias
Keyword(s):  
Hyaluronic Acid ◽  
Case Series ◽  
Dermal Filler ◽  
Hand Rejuvenation

scholarly journals Cetuximab associated dermal filler reaction

2019 ◽  
Vol 12 (8) ◽  
pp. e228882 ◽  
Author(s):  
Shivanshan Pathmanathan ◽  
Marcin Dzienis
Keyword(s):  
Epidermal Growth Factor Receptor ◽  
Radiation Therapy ◽  
Hyaluronic Acid ◽  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Growth Factor Receptor ◽  
Dermal Filler ◽  
Dermal Fillers ◽  
Epidermal Growth ◽  
Receptor Inhibitor

A 52-year-old male patient with hyaluronic acid-based dermal fillers injected in his cheeks was diagnosed with glossotonsillary malignancy, and managed with concurrent cetuximab (epidermal growth factor receptor inhibitor) and radiation therapy. He developed significant inflammation around the dermal filler sites after first cycle of cetuximab which improved with dissolution of the dermal fillers with hyaluronidase. This suggests that cetuximab can lead to inflammation around the dermal filler sites, which can be treated with dissolution of the filler.

scholarly journals Herpes reactivation after the injection of hyaluronic acid dermal filler

Medicine ◽  
2020 ◽  
Vol 99 (24) ◽  
pp. e20394
Author(s):  
Chenyu Wang ◽  
Tianyu Sun ◽  
Nanze Yu ◽  
Xiaojun Wang
Keyword(s):  
Hyaluronic Acid ◽  
Dermal Filler
Sign in / Sign up

Export Citation Format

Share Document